CCIZX
Price
$147.53
Change
+$1.27 (+0.87%)
Updated
Jun 23 closing price
Net Assets
13.58B
MTCIX
Price
$71.65
Change
+$0.80 (+1.13%)
Updated
Jun 23 closing price
Net Assets
2.01B
Interact to see
Advertisement

CCIZX vs MTCIX

Header iconCCIZX vs MTCIX Comparison
Open Charts CCIZX vs MTCIXBanner chart's image
Columbia Seligman Tech & Info Inst
Price$147.53
Change+$1.27 (+0.87%)
VolumeN/A
Net Assets13.58B
MFS Technology I
Price$71.65
Change+$0.80 (+1.13%)
VolumeN/A
Net Assets2.01B
CCIZX vs MTCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CCIZX vs. MTCIX commentary
Jun 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCIZX is a Buy and MTCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CCIZX has more cash in the bank: 13.6B vs. MTCIX (2.01B). CCIZX (0.00) and MTCIX (0.00) have matching dividends . CCIZX was incepted earlier than MTCIX: CCIZX (15 years) vs MTCIX (28 years). CCIZX (0.93) and MTCIX (0.89) have similar cost to investors . CCIZX is a more actively managed with annual turnover of: 39.00 vs. MTCIX (37.00). MTCIX has a lower initial minimum investment than CCIZX: MTCIX (0) vs CCIZX (2000). CCIZX annual gain was more profitable for investors over the last year : -3.71 vs. MTCIX (-4.42). CCIZX return over 5 years is better than : 59.17 vs. MTCIX (20.53).
CCIZXMTCIXCCIZX / MTCIX
Total Expense Ratio0.930.88106%
Annual Report Gross Expense Ratio0.930.89104%
Fund Existence15 years28 years-
Gain YTD-1.369-0.478287%
Front LoadN/AN/A-
Min. Initial Investment20000-
Min. Initial Investment IRAN/AN/A-
Net Assets13.6B2.01B676%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.71-4.4284%
Returns for 3 years32.1534.6293%
Returns for 5 years59.1720.53288%
Returns for 10 years122.72164.4675%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XPH40.960.44
+1.08%
SPDR® S&P Pharmaceuticals ETF
NUMV35.600.37
+1.05%
Nuveen ESG Mid-Cap Value ETF
XUSP40.350.37
+0.92%
Innovator Uncapped Accelerated US Eq ETF
DFAX28.870.21
+0.73%
Dimensional World ex US Core Eq 2 ETF
CLOI52.94N/A
N/A
VanEck CLO ETF